Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)

NCT02333851 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

72

Enrollment

OTHER

Sponsor class

Stopped Safety reasons

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Mixtard 30:70 Novonordisk® twice daily
DRUG: Lantus® once daily and Apidra® before meals

Sponsor

Hospital Universitario Central de Asturias

Collaborators

[object Object]